Wedbush Downgrades Xylem (XYL) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St set for tepid open as oil prices fall, Treasury yields rise
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
DA Davidson Downgrades Xylem (XYL) to Underperform
July 31, 2013 2:37 PM EDTDA Davidson downgraded Xylem (NYSE: XYL) from Neutral to Underperform with a price target of $23.00 (from $28.00).
For an analyst ratings summary and ratings history on Xylem click here. For more ratings news on Xylem click here.
Shares of Xylem closed at $25.54 yesterday, with a 52 week range of $22.43-$29.79.... More
Atlantic Equities Downgrades Xylem (XYL) to Neutral
July 31, 2013 6:55 AM EDTAtlantic Equities downgraded Xylem (NYSE: XYL) from Overweight to Neutral.
For an analyst ratings summary and ratings history on Xylem click here. For more ratings news on Xylem click here.
Shares of Xylem closed at $25.54 yesterday, with a 52 week range of $22.43-$29.79.... More
Canaccord Genuity Downgrades Xylem (XYL) to Hold
July 31, 2013 6:54 AM EDTCanaccord Genuity downgraded Xylem (NYSE: XYL) from Buy to Hold with a price target of $27.00 (from $31.50).
For an analyst ratings summary and ratings history on Xylem click here. For more ratings news on Xylem click here.
Shares of Xylem closed at $25.54 yesterday, with a 52 week range of $22.43-$29.79.... More
BB&T Capital Downgrades Xylem (XYL) to Hold
July 30, 2013 1:28 PM EDTBB&T Capital downgraded Xylem (NYSE: XYL) from Buy to Hold.
For an analyst ratings summary and ratings history on Xylem click here. For more ratings news on Xylem click here.
Shares of Xylem closed at $28.46 yesterday, with a 52 week range of $22.43-$29.79.... More
Brean Capital Downgrades Xylem (XYL) to Hold
July 30, 2013 9:09 AM EDTBrean Capital downgraded Xylem (NYSE: XYL) from Buy to Hold. The downgrade follows disappointing Q2 results.
"Xylem's 2Q13 EPS results and 2013 guidance revisions have changed our investment thesis on the name. Adjusted EPS of $0.36 was well below consensus of $0.44, and the new full... More
